Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 35 clinical trials
featured
Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003

The objectives of this trial are to evaluate the safety and tolerability of perfluorohexyloctane (NOV03) ophthalmic solution during long-term use in subjects with Dry Eye

  • 104 views
  • 16 Jun, 2020
  • 1 location
featured
DE-117 Spectrum 5 Study

Santen will evaluate the intraocular pressure (IOP) lowering effect and efficacy of DE-117 ophthalmic solution 0.002% in latanoprost/non-responder subjects diagnosed with POAG or OHT &nbsp

glaucoma
latanoprost
corrected visual acuity
intraocular pressure
ophthalmic solution
  • 69 views
  • 23 Nov, 2020
  • 1 location
featured
  • 428 views
  • 08 Nov, 2020
  • 1 location
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

The objectives of this study are: To evaluate the efficacy of Nyxol to improve mesopic low contrast visual acuity (mLCVA) in subjects with Dim Light Vision Disturbances (DLD) To evaluate efficacy of Nyxol to improve visual performance To evaluate the safety of Nyxol

  • 0 views
  • 16 Jan, 2021
  • 9 locations
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract

The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract

senile cataract
ophthalmic solution
corrected visual acuity
  • 775 views
  • 07 Nov, 2020
  • 4 locations
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

Two different dosing regimens (QD and BID) of netarsudil will be studied to evaluate their efficacy in reducing or resolving corneal edema in subjects with FCD.

  • 12 views
  • 19 Oct, 2020
  • 3 locations
Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)

SDP-4-CS202 is a Phase 2, multicenter, double-masked, randomized, vehicle-controlled, parallel group study designed to evaluate the ocular efficacy of SDP-4 ophthalmic solution in subjects with

  • 17 views
  • 25 Jan, 2021
  • 5 locations
Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia

The objective of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of AGN-241622 ophthalmic solution for the first time in human participants

ocular disease
ophthalmic solution
  • 17 views
  • 01 Dec, 2020
  • 1 location
Study to Evaluate OXERVATE in Patients With Stage 1 Neurotrophic Keratitis

This study is to evaluate the safety and efficacy of OXERVATE 0.002% (20 mcg/mL) cenegermin-bkbj ophthalmic solution in patients with Stage 1 neurotrophic keratitis (NK).

  • 0 views
  • 14 Jan, 2021
  • 5 locations
Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease

To evaluate the benefit of treatment with a physician administered intracanalicular dexamethasone insert in patients with dry eye who are beginning treatment with Xiidra (lifitegrast ophthalmic

dexamethasone
ophthalmic solution
lifitegrast
xiidra
lifitegrast ophthalmic solution
  • 0 views
  • 25 Jan, 2021
  • 1 location